BIOMAT Database Logo BIOMAT Database Logo

[Effect of melanostatin on the central nervous system]. 1983

N E Chepurnova, and V M Borzenkov, and S A Chepurnov

The effect of melanostatin (MIF), L-DOPA and morphine on the behaviour and electrical activity in the neocortex and lymbic structures in rats has been strudied. All substances were administered intraventricularly. There was a recorded increase of the energy of the delta and theta slow waves in the hypothalamus, amygdala and neocortex and also of the energy of the alfa waves in the amygdala and neocortex. In addition the administration of L-DOPA and morphine facilitated the effect of MIF while preliminary administration of MIF blocked the effect of morphine given in threshold doses.

UI MeSH Term Description Entries
D008297 Male Males
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009075 MSH Release-Inhibiting Hormone A hypothalamic tripeptide, enzymatic degradation product of OXYTOCIN, that inhibits the release of MELANOCYTE-STIMULATING HORMONES. MSH Release-Inhibiting Factor,Melanocyte-Stimulating Hormone Release-Inhibiting Hormone,Prolyl-Leucyl-Glycinamide,H-Pro-Leu-Gly-NH2,MIF-1,MIF-I,Melanocyte-Stimulating Hormone Release-Inhibiting Factor,Melanostatin,Oxytocin (7-9),Pro-Leu-Gly-NH2,Pro-Leu-Glyamide,Prol-Leu-Gly-NH2,Prolylleucylglycinamide,Prol Leu Gly NH2,Prolyl Leucyl Glycinamide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

N E Chepurnova, and V M Borzenkov, and S A Chepurnov
Central nervous system resistance; the effect of adrenal cortical substances on the central nervous system.
November 1947, Journal of neurosurgery,
N E Chepurnova, and V M Borzenkov, and S A Chepurnov
[Effect of pentazocine on the central nervous system].
March 1971, Masui. The Japanese journal of anesthesiology,
N E Chepurnova, and V M Borzenkov, and S A Chepurnov
[Effect of corticosteroids on the central nervous system].
December 1962, Ugeskrift for laeger,
N E Chepurnova, and V M Borzenkov, and S A Chepurnov
[Effect of triquinol on the central nervous system].
January 1978, Eksperimentalna meditsina i morfologiia,
N E Chepurnova, and V M Borzenkov, and S A Chepurnov
[Effect of hormones on the central nervous system].
January 1953, Uspekhi sovremennoi biologii,
N E Chepurnova, and V M Borzenkov, and S A Chepurnov
Effect of aging on the central nervous system.
May 1963, Journal of the American Geriatrics Society,
N E Chepurnova, and V M Borzenkov, and S A Chepurnov
[Effect of hormones on the central nervous system].
January 1961, Problemes actuels d'endocrinologie et de nutrition,
N E Chepurnova, and V M Borzenkov, and S A Chepurnov
[Effect of dimedrol on the central nervous system].
January 1956, Farmakologiia i toksikologiia,
N E Chepurnova, and V M Borzenkov, and S A Chepurnov
[Effect of irradiation on the central nervous system].
June 1970, Gan no rinsho. Japan journal of cancer clinics,
N E Chepurnova, and V M Borzenkov, and S A Chepurnov
[Effect of thyroliberin on the central nervous system].
January 1987, Problemy endokrinologii,
Copied contents to your clipboard!